Urgent.News

What's breaking now, across hundreds of outlets.

Business

QuidelOrtho appoints Sanjeev Sharma as VP of investor relations

QuidelOrtho appoints Sanjeev Sharma as VP of investor relations

QuidelOrtho Corporation, a company listed on the NASDAQ under the symbol QDEL, has announced the appointment of Sanjeev Sharma as their Vice President of Investor Relations, effective September 28th. The company made this announcement through a press release.

Sharma brings to his new role a wealth of experience in the field of investor relations, corporate strategy, and equity research. He has been in the industry for over two decades, having spent the last year working as the Senior Director of Investor Relations at Teva Pharmaceuticals. Here, he collaborated with senior leadership on investor communications.

Prior to that, Sharma spent over a decade at Genpact, where he held various investor relations and business strategy roles. He also spent nearly six years in sell-side equity research. Sharma holds a master's degree in finance and is a Chartered Financial Analyst, which further adds to his qualifications for this role.

In a statement, Micah Young, Chief Financial Officer of QuidelOrtho, expressed his pleasure at welcoming Sharma to the company. He praised Sharma's combination of investor relations leadership, healthcare experience, financial expertise, and perspective on capital markets. QuidelOrtho provides diagnostic solutions across clinical chemistry, immunoassay, immunohematology, and molecular testing.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at investing.com →

Report a problem with this story

More in Business

More from Wednesday 7 October →